Global Alzheimer s Disease Diagnostic Market

Global Alzheimer’s Disease Diagnostic Market Status and Outlook 2024-2029

Global Alzheimer s Disease Diagnostic Market

Global Alzheimer’s Disease Diagnostic Market Status and Outlook 2024-2029


The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.

We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.

Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.

The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.

We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.

The report will conduct a comprehensive and professional analysis of the Alzheimer’s Disease Diagnostic market in 2024 based on the current situation, global economic impact and other aspects.

Market Segment by Product Type

Nervous System Examination

Genetic Testing

Minor Mental State Examination (Mmse)

Brain Imaging

Market Segment by Product Application

Early-Onset Alzheimer's Disease

Familial Alzheimer's Disease

Late-Onset Alzheimer's Disease

Finally, the report provides detailed profile and data information analysis of leading company.

Eli Lilly and Company

Accera

F. Hoffmann-La Roche

Novartis

Alector

Merck

Neuro-Bio

TauRx

Pfizer

Treventis Corporation

Cognition Therapeutics

Insights and Tools:

This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.

The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.

Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.

The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.

Research Objectives

1.To define, describe and forecast the Alzheimer’s Disease Diagnostic market by type, application, end user and region

2.Provide enterprise external environment analysis and SWOT analysis

3.Focuses on the key global Alzheimer’s Disease Diagnostic manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.

4.Provide market entry strategy analysis for new players or players preparing to enter the market

5.Keep up with international market trends and analyze the impact of the important international events on major global regions

6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape

Global Alzheimer’s Disease Diagnostic Market Status and Outlook 2024-2029

Market Study Overview

1.1 Study Objectives

1.2 Alzheimer’s Disease Diagnostic Introduce

1.3 Combined with the Analysis of Macroeconomic Indicators

1.4 Brief Description of Research methods

1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary

2.1 Alzheimer’s Disease Diagnostic Segment by Type

2.1.1 Nervous System Examination

2.1.2 Genetic Testing

2.1.3 Minor Mental State Examination (Mmse)

2.1.4 Brain Imaging

2.2 Market Analysis by Application

2.2.1 Early-Onset Alzheimer's Disease

2.2.2 Familial Alzheimer's Disease

2.2.3 Late-Onset Alzheimer's Disease

2.3 Global Alzheimer’s Disease Diagnostic Market Comparison by Regions (2019-2029)

2.3.1 Global Alzheimer’s Disease Diagnostic Market Size (2019-2029)

2.3.2 North America Alzheimer’s Disease Diagnostic Status and Prospect (2019-2029)

2.3.3 Europe Alzheimer’s Disease Diagnostic Status and Prospect (2019-2029)

2.3.4 Asia-pacific Alzheimer’s Disease Diagnostic Status and Prospect (2019-2029)

2.3.5 South America Alzheimer’s Disease Diagnostic Status and Prospect (2019-2029)

2.3.6 Middle East & Africa Alzheimer’s Disease Diagnostic Status and Prospect (2019-2029)

2.5 Coronavirus Disease 2020 (Covid-19): Alzheimer’s Disease Diagnostic Industry Impact

2.5.1 Alzheimer’s Disease Diagnostic Business Impact Assessment - Covid-19

2.5.2 Market Trends and Alzheimer’s Disease Diagnostic Potential Opportunities in the COVID-19 Landscape

2.5.3 Measures / Proposal against Covid-19

3 Competition by Vendors

3.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Vendors (2019-2024)

3.2 Global Alzheimer’s Disease Diagnostic Industry Concentration Ratio (CR5 and HHI)

3.3 Top 5 Alzheimer’s Disease Diagnostic Vendors Market Share

3.4 Top 10 Alzheimer’s Disease Diagnostic Vendors Market Share

3.5 Date of Key Vendors Enter into Alzheimer’s Disease Diagnostic Market

3.6 Key Vendors Alzheimer’s Disease Diagnostic Product Offered

3.7 Mergers & Acquisitions Planning

4 Analysis of Alzheimer’s Disease Diagnostic Industry Key Vendors

4.1 Eli Lilly and Company

4.1.1 Company Details

4.1.2 Product Introduction, Application and Specification

4.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.1.4 Main Business Overview

4.1.5 Eli Lilly and Company News

4.2 Accera

4.2.1 Company Details

4.2.2 Product Introduction, Application and Specification

4.2.3 Accera Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.2.4 Main Business Overview

4.2.5 Accera News

4.3 F. Hoffmann-La Roche

4.3.1 Company Details

4.3.2 Product Introduction, Application and Specification

4.3.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.3.4 Main Business Overview

4.3.5 F. Hoffmann-La Roche News

4.4 Novartis

4.4.1 Company Details

4.4.2 Product Introduction, Application and Specification

4.4.3 Novartis Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.4.4 Main Business Overview

4.4.5 Novartis News

4.5 Alector

4.5.1 Company Details

4.5.2 Product Introduction, Application and Specification

4.5.3 Alector Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.5.4 Main Business Overview

4.5.5 Alector News

4.6 Merck

4.6.1 Company Details

4.6.2 Product Introduction, Application and Specification

4.6.3 Merck Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.6.4 Main Business Overview

4.6.5 Merck News

4.7 Neuro-Bio

4.7.1 Company Details

4.7.2 Product Introduction, Application and Specification

4.7.3 Neuro-Bio Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.7.4 Main Business Overview

4.7.5 Neuro-Bio News

4.8 TauRx

4.8.1 Company Details

4.8.2 Product Introduction, Application and Specification

4.8.3 TauRx Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.8.4 Main Business Overview

4.8.5 TauRx News

4.9 Pfizer

4.9.1 Company Details

4.9.2 Product Introduction, Application and Specification

4.9.3 Pfizer Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.9.4 Main Business Overview

4.9.5 Pfizer News

4.10 Treventis Corporation

4.10.1 Company Details

4.10.2 Product Introduction, Application and Specification

4.10.3 Treventis Corporation Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.10.4 Main Business Overview

4.10.5 Treventis Corporation News

4.11 Cognition Therapeutics

4.11.1 Company Details

4.11.2 Product Introduction, Application and Specification

4.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Gross Margin, and Revenue (2019-2024)

4.11.4 Main Business Overview

4.11.5 Cognition Therapeutics News

5 Global Alzheimer’s Disease Diagnostic Market Size Categorized by Regions

5.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Regions

5.2 North America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

5.3 Europe Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

5.4 Asia-pacific Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

5.5 South America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

5.6 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

6 North America Alzheimer’s Disease Diagnostic Market Size Categorized by Countries

6.1 North America Alzheimer’s Disease Diagnostic Revenue and Market Share by Countries

6.1.1 North America Alzheimer’s Disease Diagnostic Market Size by Countries (2019-2024)

6.1.2 United States Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

6.1.3 Canada Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

6.1.4 Mexico Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

6.2 North America Alzheimer’s Disease Diagnostic Revenue (Value) by Vendors

6.3 North America Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2019-2024)

6.4 North America Alzheimer’s Disease Diagnostic Revenue and Market Share by Application (2019-2024)

7 Europe Alzheimer’s Disease Diagnostic Market Size Categorized by Countries

7.1 Europe Alzheimer’s Disease Diagnostic Revenue and Market Share by Countries

7.1.1 Europe Alzheimer’s Disease Diagnostic Market Size by Countries (2019-2024)

7.1.2 Germany Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.1.3 UK Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.1.4 France Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.1.5 Russia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.1.6 Italy Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.1.7 Spain Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

7.2 Europe Alzheimer’s Disease Diagnostic Revenue (Value) by Vendors

7.3 Europe Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2019-2024)

7.4 Europe Alzheimer’s Disease Diagnostic Revenue and Market Share by Application (2019-2024)

8 Asia-pacific Alzheimer’s Disease Diagnostic Market Size Categorized by Countries

8.1 Asia-pacific Alzheimer’s Disease Diagnostic Revenue and Market Share by Countries

8.1.1 Asia-pacific Alzheimer’s Disease Diagnostic Market Size by Countries (2019-2024)

8.1.2 China Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.1.3 South Korea Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.1.4 Japan Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.1.5 Australia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.1.6 India Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.1.7 Southeast Asia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

8.2 Asia-pacific Alzheimer’s Disease Diagnostic Revenue (Value) by Vendors

8.3 Asia-pacific Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2019-2024)

8.4 Asia-pacific Alzheimer’s Disease Diagnostic Revenue and Market Share by Application (2019-2024)

9 South America Alzheimer’s Disease Diagnostic Market Size Categorized by Countries

9.1 South America Alzheimer’s Disease Diagnostic Revenue and Market Share by Countries

9.1.1 South America Alzheimer’s Disease Diagnostic Market Size by Countries (2019-2024)

9.1.2 Brazil Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

9.1.3 Chile Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

9.2 South America Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2019-2024)

9.3 South America Alzheimer’s Disease Diagnostic Revenue and Market Share by Application (2019-2024)

10 Middle East and Africa Alzheimer’s Disease Diagnostic Market Size Categorized by Countries

10.1 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue and Market Share by Countries

10.1.1 Middle East and Africa Alzheimer’s Disease Diagnostic Market Size by Countries (2019-2024)

10.1.2 GCC Countries Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

10.1.3 Turkey Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

10.1.4 Egypt Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

10.1.5 South Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2019-2024)

10.2 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue and Market Share by Type

10.3 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2019-2024)

11 Global Alzheimer’s Disease Diagnostic Market Segment by Type

11.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2019-2024)

11.2 Nervous System Examination Revenue Growth Rate and Price

11.3 Genetic Testing Revenue Growth Rate and Price

11.4 Minor Mental State Examination (Mmse) Revenue Growth Rate and Price

11.5 Brain Imaging Revenue Growth Rate and Price

12 Global Alzheimer’s Disease Diagnostic Market Segment by Application

12.1 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2019-2024)

12.2 Early-Onset Alzheimer's Disease Revenue Growth Rate (2019-2024)

12.3 Familial Alzheimer's Disease Revenue Growth Rate (2019-2024)

12.4 Late-Onset Alzheimer's Disease Revenue Growth Rate (2019-2024)

13 Global Alzheimer’s Disease Diagnostic Market Forecast

13.1 Global Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2024-2029)

13.2 Alzheimer’s Disease Diagnostic Market Forecast by Regions (2024-2029)

13.2.1 North America Alzheimer’s Disease Diagnostic Market Forecast (2024-2029)

13.2.2 Europe Alzheimer’s Disease Diagnostic Market Forecast (2024-2029)

13.2.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Forecast (2024-2029)

13.2.4 South America Alzheimer’s Disease Diagnostic Market Forecast (2024-2029)

13.2.5 Middle East & Africa Alzheimer’s Disease Diagnostic Market Forecast (2024-2029)

13.3 Alzheimer’s Disease Diagnostic Market Forecast by Type (2024-2029)

13.3.1 Global Alzheimer’s Disease Diagnostic Revenue Forecast by Type (2024-2029)

13.3.2 Global Alzheimer’s Disease Diagnostic Market Share Forecast by Type (2024-2029)

13.4 Alzheimer’s Disease Diagnostic Market Forecast by Application (2024-2029)

13.4.1 Global Alzheimer’s Disease Diagnostic Revenue Forecast by Application (2024-2029)

14 Market Analysis

14.1.1 Market overview

14.1.2 Market Opportunities

14.1.3 Market Risk

14.1.4 Market Driving Force

14.1.5 Porter's Five Forces Analysis

14.1.6 SWOT Analysis

15 Downstream Market Analysis

15.1 Macro Analysis of Down Markets

15.2 Key Players in Down Markets

16 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Alzheimer’s Disease Diagnostic Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Alzheimer’s Disease Diagnostic Market trending toward high growth trajectories?
A dynamic process in the Alzheimer’s Disease Diagnostic Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Roche, Eli Lilly, Biogen, Siemens Healthineers, Quest Diagnostics.
What is the Alzheimer’s Disease Diagnostic Market really preparing for?
Companies in the Alzheimer’s Disease Diagnostic Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
Where are the Alzheimer’s Disease Diagnostic used?
The Alzheimer’s Disease Diagnostic are employed in Hospitals, Research Centers, Home Healthcare, Clinics.
What is the estimated value of the Alzheimer’s Disease Diagnostic Market?
The Alzheimer’s Disease Diagnostic Market is expected to reach a reasonable valuation by 2030; now the market is expected to shift its focus from growth to value.
What trends may have an impact on the Alzheimer’s Disease Diagnostic Market's growth?
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Alzheimer’s Disease Diagnostic Market as well as its distribution among its players
What makes the latest Alzheimer’s Disease Diagnostic Market study unique?
The latest version of the Alzheimer’s Disease Diagnostic Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.